Allison Kwon

Healthcare Policy Consultant

Overview

Allison Kwon supports Crowell Health Solutions, a strategic consulting firm affiliated with Crowell & Moring, to help clients pursue and deliver innovative alternatives to the traditional approaches of providing and paying for health care, including through digital health, health equity, and value-based health care. She is a health care policy consultant in the Washington, D.C. office.

Prior to joining Crowell Health Solutions, Allison worked at a health care provider association, where she analyzed legislative and regulatory issues relevant to hospitals and continuing care facilities. In this role, she tracked developments in federal health care programs and worked on numerous policy issues. She also interned at a D.C. government affairs firm, the U.S. Attorney’s Office for the District of Columbia, and offices in the U.S. House of Representatives and U.S. Senate.

Career & Education

    • The George Washington University, B.A., 2020
      magna cum laude
    • The George Washington University, B.A., 2020
      magna cum laude

Allison 's Insights

Client Alert | 7 min read | 07.29.25

White House AI Action Plan: Potential Implications for Health Care

On July 23, 2025, the Trump Administration issued an artificial intelligence (AI) action plan titled “Winning the Race: America’s AI Action Plan” (the Plan) to guide AI innovation in the U.S. The Plan includes 90 policy recommendations that will shape future AI guidance and policies impacting a range of entities and industry sectors, including health care/life sciences and entities involved in clinical research....

Allison 's Insights

Client Alert | 7 min read | 07.29.25

White House AI Action Plan: Potential Implications for Health Care

On July 23, 2025, the Trump Administration issued an artificial intelligence (AI) action plan titled “Winning the Race: America’s AI Action Plan” (the Plan) to guide AI innovation in the U.S. The Plan includes 90 policy recommendations that will shape future AI guidance and policies impacting a range of entities and industry sectors, including health care/life sciences and entities involved in clinical research....